PL3077512T3 - Immunogenne kompozycje i szczepionki pochodzące od bakteryjnych białek receptora powierzchniowego - Google Patents

Immunogenne kompozycje i szczepionki pochodzące od bakteryjnych białek receptora powierzchniowego

Info

Publication number
PL3077512T3
PL3077512T3 PL14866832.0T PL14866832T PL3077512T3 PL 3077512 T3 PL3077512 T3 PL 3077512T3 PL 14866832 T PL14866832 T PL 14866832T PL 3077512 T3 PL3077512 T3 PL 3077512T3
Authority
PL
Poland
Prior art keywords
surface receptor
immunogenic compositions
receptor proteins
bacterial surface
vaccines derived
Prior art date
Application number
PL14866832.0T
Other languages
English (en)
Inventor
Anthony B. Schryvers
Trevor F. MORAES
Scott Gray-Owen
Original Assignee
Engineered Antigens Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Engineered Antigens Inc. filed Critical Engineered Antigens Inc.
Publication of PL3077512T3 publication Critical patent/PL3077512T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A61K39/1045—Moraxella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL14866832.0T 2013-12-02 2014-12-01 Immunogenne kompozycje i szczepionki pochodzące od bakteryjnych białek receptora powierzchniowego PL3077512T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361910817P 2013-12-02 2013-12-02
US201462007068P 2014-06-03 2014-06-03
PCT/CA2014/051146 WO2015081430A1 (en) 2013-12-02 2014-12-01 Immunogenic compositions and vaccines derived from bacterial surface receptor proteins

Publications (1)

Publication Number Publication Date
PL3077512T3 true PL3077512T3 (pl) 2022-07-18

Family

ID=53272682

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14866832.0T PL3077512T3 (pl) 2013-12-02 2014-12-01 Immunogenne kompozycje i szczepionki pochodzące od bakteryjnych białek receptora powierzchniowego

Country Status (14)

Country Link
US (2) US10149900B2 (pl)
EP (2) EP4074830A3 (pl)
JP (1) JP2016539950A (pl)
KR (2) KR20160110368A (pl)
CN (2) CN105980562B (pl)
AU (1) AU2014360590B2 (pl)
BR (1) BR112016012285A2 (pl)
CA (1) CA2931685C (pl)
DK (1) DK3077512T3 (pl)
EA (1) EA037909B1 (pl)
ES (1) ES2912751T3 (pl)
NZ (1) NZ721121A (pl)
PL (1) PL3077512T3 (pl)
WO (1) WO2015081430A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017136947A1 (en) * 2016-02-10 2017-08-17 Moraes Trevor F Slam polynucleotides and polypeptides and uses thereof
WO2019074934A1 (en) * 2017-10-09 2019-04-18 Healthtell Inc. IMMUNOGENS FOR DIRECTED IMMUNE RESPONSE AND ANTIBODIES THEREFROM
CN109239341B (zh) * 2018-07-04 2021-08-24 西南大学 一种牛溶血性曼氏杆菌抗体检测的间接elisa试剂盒及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268463A (en) 1986-11-11 1993-12-07 Jefferson Richard A Plant promoter α-glucuronidase gene construct
US5292869A (en) 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
FR2682114B1 (fr) 1991-10-03 1996-02-23 Pasteur Merieux Serums Vacc Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie.
US5417971A (en) 1991-10-22 1995-05-23 University Of Saskatchewan Vaccines for Actinobacillus pleuropneumoniae
FR2692592B1 (fr) 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
US6361779B1 (en) 1993-11-08 2002-03-26 Aventis Pasteur Limited Transferrin receptor genes
US6048539A (en) 1995-11-02 2000-04-11 Connaught Laboratories Limited Lactoferrin receptor protein
EP0863986A1 (en) 1995-12-01 1998-09-16 Reggie Y. C. Lo Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same
US6610506B1 (en) 1995-12-01 2003-08-26 University Technologies International, Inc. Transferrin binding proteins of Pasteurella haemolytica and vaccines containing same
FR2767060B1 (fr) * 1997-08-07 2000-02-11 Pasteur Merieux Serums Vacc Vaccin meningocoque comportant la valence de souche bz83
US6391316B1 (en) 1999-03-10 2002-05-21 University Of Saskatchewan Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use
US7241449B1 (en) 1999-04-12 2007-07-10 Aventis Pasteur Limited Transferrin receptor genes of moraxella
US20040258695A1 (en) 2003-01-31 2004-12-23 Schryvers Anthony Bernard Transferrin binding peptides and uses thereof

Also Published As

Publication number Publication date
NZ721121A (en) 2020-09-25
AU2014360590A1 (en) 2016-07-14
EP3077512B1 (en) 2022-02-09
US20160303217A1 (en) 2016-10-20
EP3077512A4 (en) 2017-09-06
EP4074830A3 (en) 2023-01-18
CA2931685C (en) 2021-09-07
CA2931685A1 (en) 2015-06-11
ES2912751T3 (es) 2022-05-27
EA201691140A1 (ru) 2017-02-28
KR102507993B1 (ko) 2023-03-15
EP3077512A1 (en) 2016-10-12
EA037909B1 (ru) 2021-06-04
CN105980562A (zh) 2016-09-28
BR112016012285A2 (pt) 2017-09-26
US10149900B2 (en) 2018-12-11
KR20160110368A (ko) 2016-09-21
WO2015081430A1 (en) 2015-06-11
AU2014360590B2 (en) 2019-05-16
CN105980562B (zh) 2025-07-18
CN120771269A (zh) 2025-10-14
JP2016539950A (ja) 2016-12-22
EP4074830A2 (en) 2022-10-19
KR20200135563A (ko) 2020-12-02
US20190117756A1 (en) 2019-04-25
DK3077512T3 (da) 2022-05-16

Similar Documents

Publication Publication Date Title
IL310015B2 (en) Single vial formulation
IL279395A (en) A vaccine
IL257800A (en) Immune compositions with improved stability and immunogenicity
IL252915A0 (en) Immunogenic preparations for use in pneumococcal vaccines
ZA201506879B (en) Improved vaccines for human papilloma virus and methods for using the same
IL251120A0 (en) Immunogenic/therapeutic glycoside preparations and their uses
EP3010340A4 (en) Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency
ZA201608487B (en) Dual adjuvant vaccine compositions, preparation and uses
EP3131579A4 (en) Vaccine adjuvant compositions
IL248223B (en) Compositions of vaccine
IL234695A0 (en) Antigen compositions and methods
SG11201510617WA (en) Methods and compositions for dengue virus vaccines
GB201801566D0 (en) Methods and compositions for nanormulsion vaccine formulations
EP3137111A4 (en) Compositions and methods for intradermal vaccine delivery
EP3114968A4 (en) Height-adjustable pillow
EP3049103A4 (en) Compositions and methods for reducing antigen-specific immunogenicity
EP3041503A4 (en) Methods and compositions for viral vectored vaccines
PL3077512T3 (pl) Immunogenne kompozycje i szczepionki pochodzące od bakteryjnych białek receptora powierzchniowego
EP3078677A4 (en) Antigen chimera, antigen combination, vaccine, method of preparing same, and kit thereof
GB2547494B (en) Monovalent H5 vaccine
HK1229841B (zh) 源於细菌表面受体蛋白的免疫原性组合物和疫苗
AU2013901875A0 (en) Immunogenic vaccines and uses thereof
AU2014902031A0 (en) Immunogenic vaccines and uses thereof
HK1238256A1 (en) Monovalent h5 vaccine
HK1238256B (en) Monovalent h5 vaccine